According to the latest report by Reports and Data, the global Epinephrine Injection market is expected to reach a market size of USD 4.76 Billion by 2028 at a Compound Annual Growth Rate (CAGR) of 8.7%. One of the key drivers of market growth is the increasing demand for Epinephrine Injection auto-injectors, which are used for quick administration during emergency situations.

Other factors expected to drive market revenue growth over the forecast period include the increasing incidence of severe allergic reactions and anaphylactic shock and technological advancements in Epinephrine Injection injectors. Epinephrine Injection is widely used to restore cardiac rhythm, control asthma, and treat life-threatening allergic reactions, which is also expected to boost demand for Epinephrine Injection products and contribute to market growth in the future.

Get a free sample PDF of the report, visit @

https://www.reportsanddata.com/download-free-sample/91

Epinephrine Injection, or adrenaline, is a hormone and neurotransmitter that has vasoconstricting, intraocular pressure-reducing, and bronchodilating activities. Epinephrine Injection is widely used as it can function both as a medication and hormone. The FDA has approved Epinephrine Injection for the treatment of type 1 hypersensitivity reaction, cardiac arrest, and asthma attacks, and it has several off-label uses.

Epinephrine Injection plays an important role in the fight-or-flight response by increasing blood flow to muscles. Depending on the diagnosis, Epinephrine Injection administration varies, such as intravenous, injection into muscles, inhalation, or injecting just under the skin.

The increasing demand for Epinephrine Injection auto-injectors for quick emergency response is expected to be a key market growth driver. However, the side effects of Epinephrine Injection, such as high blood pressure, headache, abnormal heart rhythm in some cases, and anxiety among others, can hamper market growth to a certain extent over the forecast period.

The report highlights some key trends in the industry. The Epinephrine Injection auto-injector segment is expected to register significant revenue growth over the forecast period due to growing demand for prefilled auto-injectors, affordable generic Epinephrine Injection products, and innovations in auto-injectors. The anaphylaxis segment is expected to account for a significant share in the global market due to the increasing incidence of anaphylactic allergic reactions and the increasing number of people susceptible to allergies. Epinephrine Injection is the primary treatment approach for anaphylaxis.

North America is expected to account for the largest revenue share in the global market due to the increasing number of people with life-threatening food allergies, the rise in chronic illnesses due to allergies, the presence of robust healthcare facilities, and the rapid launch of advanced Epinephrine Injection injections and products.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/91

Key companies in the market include Abbott Laboratories, Lincoln Medical, Ltd., Mylan, Inc., Sanofi SA, Amedra Pharmaceuticals LLC, and ALK Abello A/S.

In June 2021, Alerje Inc., a food allergy management company based in Detroit, introduced a smartphone case equipped with an auto-injector that rapidly releases Epinephrine Injection during severe allergic reactions. It will also automatically alert the patients' support circle through the Alerje smartphone app when a dose is discharged from the case.

For the purpose of the report, Reports and Data has segmented the global Epinephrine Injection market based on type, application, and region. The type outlook includes Epinephrine Injection auto-injector, Epinephrine Injection prefilled syringe, and others. The application outlook includes anaphylaxis and others. The regional outlook includes North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, BENELUX), Asia Pacific (China, India, Japan, South Korea, rest of APAC), Latin America (Brazil, Rest of Latin America)

Request a customized copy of the report @

https://www.reportsanddata.com/request-customization-form/91

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Browse for more reports…

https://www.reportsanddata.com/report-detail/companion-animal-health-market

https://www.reportsanddata.com/report-detail/long-term-care-services-market